Key result
Patients in complete remission 6 weeks posttherapy for small cell lung cancer had significantly lower peak VO2 and muscular endurance than healthy controls and post-CABG cardiac patients (p<0.05).
Why the study?
How does the physical fitness of patients 6 weeks posttherapy for small cell lung cancer compare to recent CABG patients and healthy controls?
Cross-Sectional (n=11)
How does the physical fitness of patients 6 weeks posttherapy for small cell lung cancer compare to recent CABG patients and healthy controls?
p-value: p=<0.05
Patients with small cell lung cancer 6 weeks posttherapy have significantly diminished cardiorespiratory and muscular capacities compared to both healthy controls and recent CABG patients.
No takes yet. Share an insight, caveat, or question.
Post-SCLC survivors may need cautious exercise guidance given lower fitness than CABG peers; leaves open SCLC-specific rehab trials.
Baracos et al. (1994) conducted a cross-sectional in Small cell lung cancer (n=11). History of small cell lung cancer vs. Age- and sex-matched post-CABG cardiac patients and healthy controls was evaluated on Peak aerobic power (VO2), muscular strength, and endurance (p=<0.05). Patients in complete remission 6 weeks posttherapy for small cell lung cancer had significantly lower peak VO2 and muscular endurance than healthy controls and post-CABG cardiac patients (p<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: